Comparative pharmacodynamics of imipenem, doripenem, meropenem, and ertapenem in combination with polymyxin B against carbapenem-resistant

被引：0
|
作者：
Gall, Jonathan [1 ]
Lenhard, Justin [1 ]
Holden, Patricia N. [2 ]
Tsuji, Brian T. [2 ]
机构：
[1] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Buffalo, NY 14260 USA
[2] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Lab Antimicrobial Pharmacodynam, Buffalo, NY 14260 USA
来源：
PHARMACOTHERAPY | 2015年 / 35卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
496
引用
收藏
页码：E304 / E305
页数：2
相关论文
共 50 条
  • [31] Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
    Zusman, Oren
    Altunin, Sergey
    Koppel, Fidi
    Benattar, Yael Dishon
    Gedik, Habip
    Paul, Mical
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (01) : 29 - 39
  • [32] In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore
    Lim, Tze-Peng
    Tan, Thean-Yen
    Lee, Winnie
    Sasikala, S.
    Tan, Thuan-Tong
    Hsu, Li-Yang
    Kwa, Andrea L.
    PLOS ONE, 2011, 6 (04):
  • [33] Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections
    Saballs, Mireia
    Pujol, Miquel
    Tubau, Fe
    Pena, Carmen
    Montero, Abelardo
    Dominguez, M. Angeles
    Gudiol, Francesc
    Ariza, Javier
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (03) : 697 - 700
  • [34] Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia
    Tang, Hung-Jen
    Chuang, Yin-Ching
    Ko, Wen-Chien
    Chen, Chi-Chung
    Shieh, Jiunn-Min
    Chen, Chung-Hua
    Lee, Nan-Yao
    Chiang, Shyh-Ren
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (01) : E34 - E40
  • [35] Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens
    Biagi, M.
    Shajee, A.
    Vialichka, A.
    Jurkovic, M.
    Tan, X.
    Wenzler, E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (04)
  • [36] Polymyxin B in Combination with Rifampin and Meropenem against Polymyxin B-Resistant KPC-Producing Klebsiella pneumoniae
    Diep, John K.
    Jacobs, David M.
    Sharma, Rajnikant
    Covelli, Jenna
    Bowers, Dana R.
    Russo, Thomas A.
    Rao, Gauri G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (02)
  • [37] Auranofin promotes antibacterial effect of doripenem against carbapenem-resistant Acinetobacter baumannii
    Kim, Hye-Rim
    Eom, Yong-Bin
    JOURNAL OF APPLIED MICROBIOLOGY, 2022, 133 (03) : 1422 - 1433
  • [38] Fingolimod Promotes Antibacterial Effect of Doripenem against Carbapenem-Resistant Escherichia coli
    Jin, Hye-Won
    Kim, Hye-Rim
    Eom, Yong-Bin
    ANTIBIOTICS-BASEL, 2022, 11 (08):
  • [39] Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an In Vitro Pharmacodynamic Model
    Beganovic, Maya
    Daffinee, Kathryn E.
    Luther, Megan K.
    LaPlante, Kerry L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (03)
  • [40] In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
    Yi-Fan Hu
    Chang-Pan Liu
    Nai-Yu Wang
    Shou-Chuan Shih
    BMC Infectious Diseases, 16
12345